Trial Profile
Safety and Efficacy of Inotuzumab Ozogamicin in Patient with Hematologic Malignancy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2018
Price :
$35
*
At a glance
- Drugs Inotuzumab ozogamicin (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 27 Aug 2018 New trial record
- 18 Aug 2018 Results published in the Hepatology